# A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients

> **NCT02570854** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 40 (actual)

## Conditions studied

- Anemia, Iron-Deficiency

## Interventions

- **BIOLOGICAL:** CSJ137
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02570854
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-22
- **Primary completion:** 2020-05-13
- **Final completion:** 2020-05-13
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02570854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02570854, "A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02570854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*